FDA panel recommends Novavax COVID-19 vaccine be the fourth allowed for use in US usatoday.com
A federal advisory committee recommended Tuesday that a fourth COVID-19 vaccine be authorized for use in the USA, this one from Novavax, a company based in Gaithersburg, Maryland.
voters
Report Story
Leave Your Comment